Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration

Table 2

Additional procedures during initial PPV and treatments before and after initial PPV.

	SMH	VH
Number of eyes	8	17
Treatment before initial PPV
Anti-VEGF	2	8
PDT	0	3
PC	0	1
Additional procedure during PPV
PEA-IOL	6	11
tPA	8	5
IVB	3	3
Tamponade SF6/SO/air	7/0/1	2/2/0
After initial PPV
Anti-VEGF	6	7
PDT	0	3
PC	0	3
Additional PPV	2	2

SMH: submacular hemorrhage, VH: vitreous hemorrhage, PPV: pars plana vitrectomy, VEGF: vascular endothelial growth factor, PDT: photodynamic therapy, PC: photocoagulation, PEA: phacoemulsification-aspiration, IOL: intraocular lens, tPA: tissue plasminogen activator, IVB: intravitreal bevacizumab, SO: silicone oil.